PARSATUZUMAB
UNII 435M4HCP2M

Substance Identification & Data

This profile provides standardized clinical and technical data for Parsatuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 435M4HCP2M.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1312797-14-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

435M4HCP2M

CAS Registry Number

1312797-14-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PARSATUZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C90567

National Cancer Institute reference terminology for clinical and research data.

INN ID

9647

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

ZZ-136

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Parsatuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PARSATUZUMAB

Common Names & Synonyms

PARSATUZUMAB [INN]

PARSATUZUMAB [USAN]

PARSATUZUMAB [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN PROTEIN EGFL7 (EPIDERMAL GROWTH FACTOR-LIKE DOMAIN 7)) (HUMAN-MUS MUSCULUS MONOCLONAL MEGF0444A HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL MEGF0444A .KAPPA.-CHAIN, DIMER

SYS